T-Rexx
JUB Addict
- Joined
- Dec 21, 2009
- Posts
- 6,026
- Reaction score
- 0
- Points
- 0
Hospira, the only remaining US manufacturer of sodium thiopental, has announced it will stop production of the drug at its North Carolina plant. Hospira says it is responding to complaints from its overseas customers, who object to buying drugs from a company that helps to support capital punishment.
Hospira has shifted production to a more modern plant in Lescate, Italy. The company has promised Italian authorities that none of the drug produced in Lescate will be used to put humans to death. A bill overwhelmingly passed the Italian Parliament on December 22, requiring that Hospira keep sodium thiopental made in Italy out of prisons.
Sodium thiopental is used mostly as an anesthetic, not primarily for lethal injections. It is part of a 3 drug regimen typically employed by American states during capital executions. The three drugs sedate, paralyze, and stop the heart.
All but one of the 35 US states employing the death penalty use the 3 drug protocol involving sodium thiopental. It is not so easy for states to move to other (foreign) providers of sodium thiopental, since the Hospira brand is the only one approved by the FDA for use in the USA. It is also not so easy for states to switch to alternative anesthetics, as use of sodium thiopental is typically required under state laws. So, switching will require passage of legislation in the various states (and will probably trigger a bunch of lawsuits by inmates on death row).
Of course, the vast majority of Hospira sodium thiopental manufactured in the USA was used for medical purposes, not lethal injections. Hospira has long objected to the use of its products in capital punishment, but has not previously acted to cut off the supply to authorities. The company has expressed regret that circumstances have compelled it to shift production overseas. The company continues to manufacture the other two components of the 3 drug regimen, pancuronium bromide and potassium chloride, both of which have other, medical uses.
A shortage of sodium thiopental has already delayed executions in Arizona, California, Kentucky, Ohio and Oklahoma. It is unclear what effect the permanent discontinuation of production will have on executions in the United States.
http://news.yahoo.com/s/ap/20110121/ap_on_re_us/us_execution_drug_shortage
Hospira has shifted production to a more modern plant in Lescate, Italy. The company has promised Italian authorities that none of the drug produced in Lescate will be used to put humans to death. A bill overwhelmingly passed the Italian Parliament on December 22, requiring that Hospira keep sodium thiopental made in Italy out of prisons.
Sodium thiopental is used mostly as an anesthetic, not primarily for lethal injections. It is part of a 3 drug regimen typically employed by American states during capital executions. The three drugs sedate, paralyze, and stop the heart.
All but one of the 35 US states employing the death penalty use the 3 drug protocol involving sodium thiopental. It is not so easy for states to move to other (foreign) providers of sodium thiopental, since the Hospira brand is the only one approved by the FDA for use in the USA. It is also not so easy for states to switch to alternative anesthetics, as use of sodium thiopental is typically required under state laws. So, switching will require passage of legislation in the various states (and will probably trigger a bunch of lawsuits by inmates on death row).
Of course, the vast majority of Hospira sodium thiopental manufactured in the USA was used for medical purposes, not lethal injections. Hospira has long objected to the use of its products in capital punishment, but has not previously acted to cut off the supply to authorities. The company has expressed regret that circumstances have compelled it to shift production overseas. The company continues to manufacture the other two components of the 3 drug regimen, pancuronium bromide and potassium chloride, both of which have other, medical uses.
A shortage of sodium thiopental has already delayed executions in Arizona, California, Kentucky, Ohio and Oklahoma. It is unclear what effect the permanent discontinuation of production will have on executions in the United States.
http://news.yahoo.com/s/ap/20110121/ap_on_re_us/us_execution_drug_shortage

































